Furthermore, in line with our present findings a recent study has demonstrated that the α7nAChR agonist, choline chloride, ameliorates seizure severity, memory impairment, and depression in a pentylenetetrazole-kindled mouse model of epilepsy (Sharma et al., 2020). Here, CHRNA7 is linked to depressive symptom measurement.